Teleflex Scientific Webinar
Technologic Innovations for the Prevention of Catheter-Related Bloodstream Infection
Technologies, innovations and human factors all play key roles in infection prevention. This symposia will review current strategies that promote infection prevention. After attending this presentation you will be able to recognize the significance of catheter related bloodstream infection and be empowered with the understanding that knowledge of pathogenesis drives prevention efforts. We will explore evidence -based measures to prevent CR-BSI by limiting intraluminal and extraluminal catheter contamination. In addition, discuss the technologic innovations for the prevention of catheter related bloodstream infection (CR-BSI).
Webinar Objectives:
- Recognize the significance of Catheter Related Bloodstream Infection (CR-BSI) and understand that knowledge of pathogenesis drives prevention efforts
- Describe evidence-based measures to prevent CR-BSI by limiting intraluminal and extraluminal catheter contamination
- Be able to introduce technologic innovations for the prevention of Catheter Related Bloodstream Infection (CR-BSI)
sponsor:
Speakers AND MODERATORS:
Speakers
-
Amy Bardin, EdD (c), MSc, RRT, VA-BCTM - ModeratorDirector, Global Vascular Clinical Affairs
Clinical and Medical Affairs, Teleflex Incorporated -
Mark E. Rupp MDProfessor & Chief, Infectious Diseases
Director, Infection Control & Epidemiology
University of Nebraska Medical Center
Omaha, NE USADr. Rupp is the associate medical director of the Nebraska ICAP and ASAP and is a Professor and Chief of the Division of Infectious Diseases in the Department of Internal Medicine at UNMC. He is the medical director of the Nebraska Medicine Department of Infection Control & Epidemiology.
Dr. Rupp received his medical degree from Baylor College of Medicine, Houston, Texas and holds a B.S. degree in Chemical Engineering from the University of Texas, Austin, Texas. He underwent internship and residency training in Internal Medicine and completed Fellowship training in Infectious Diseases at Virginia Commonwealth University.
He is a Diplomate, American Board of Internal Medicine, and in the subspecialty area of Infectious Diseases. He is a Fellow of the American College of Physicians (ACP), the Infectious Diseases Society of America (IDSA), and the Society for Hospital Epidemiology of America (SHEA). He is a Past-President of SHEA and is a Past-President of ASM Division L (Infection Control/Hospital Epidemiology). Dr. Rupp has served as a consultant for the US Food and Drug Administration as well as the Centers for Disease Control and Prevention, NIH, and VA.
Dr. Rupp has published over 400 articles, chapters and abstracts. He frequently presents papers at national and international meetings, serves as a guest lecturer, and is an active teacher and researcher. Dr. Rupp’s research interests are in the areas of staphylococcal disease, healthcare-associated infections, and antimicrobial resistance.